Cresset Asset Management’s NeueHealth NEUE Stock Holding History

Cresset Asset Management’s Portfolio NEUE Stock Details NEUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-175	Closed	-$3.08K	–	1929
2023 Q1	$3.08K	Sell	175 -101	-37%	-$5.21K	﹤0.01%	812
2022 Q4	$142	Buy	276 +1	+0.4%	+$73	﹤0.01%	728
2022 Q3	$23K	Hold	275	–	–	﹤0.01%	873
2022 Q2	$40K	Buy	+275	New	+$40K	﹤0.01%	916

Other funds holding NEUE

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

DMC

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return

Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return

MCAV

Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return

PGH

Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Cresset Asset Management's NEUE Position: Q2 2023 in Review

Cresset Asset Management sold out of NeueHealth (NEUE) in Q2 2023, closing a stake of 175 shares — an estimated $3.08K sold.

Cresset Asset Management first reported a position in NEUE in Q2 2022 and held it in 4 quarters. The position peaked at $40K in Q2 2022. 49 funds tracked by Wall St. Rank hold NEUE as of Q2 2023.

Cresset Asset Management reported no remaining NeueHealth position as of Q2 2023 after selling out during the quarter.
Cresset Asset Management sold 175 NeueHealth shares in Q2 2023, an estimated $3.08K.
Cresset Asset Management first reported a position in NeueHealth in Q2 2022 and held it in 4 quarters.
Cresset Asset Management's NeueHealth position peaked at $40K in Q2 2022.
49 funds tracked by Wall St. Rank held NeueHealth as of Q2 2023.

Based on Cresset Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.